In this issue of JAMA, the US Preventive Services Task Force (USPSTF) has issued new recommendations for hepatitis C virus (HCV) infection screening in the asymptomatic US population.1 Based on an updated review of the evidence,2 the task force now “recommends screening for HCV infection in adults aged 18 to 79 years (B recommendation),”1 regardless of known risk factors. Adolescents who engage in injection drug use or other behaviors associated with acquisition of HCV should also be screened. Screening all adults has been shown to be cost-effective, and a B recommendation means that insurance companies will provide reimbursement for hepatitis C testing without cost-sharing by patients.
Graham CS, Trooskin S. Universal Screening for Hepatitis C Virus Infection: A Step Toward Elimination. JAMA. 2020;323(10):936–937. doi:10.1001/jama.2019.22313
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: